Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emp ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors rely on traditional forms of analysis on key valuation metrics to fi ...

期权市场动态 - 投资者需密切关注Dentsply Sirona Inc (XRAY)股票 因2025年7月18日到期 行权价7 50美元的看涨期权隐含波动率创当日所有股票期权最高水平 [1] - 高隐含波动率表明市场预期标的股票将出现大幅波动 可能由即将发生的事件引发 但隐含波动率仅是期权交易策略的参考因素之一 [2] 公司基本面分析 - 公司属于医疗牙科供应行业 在Zacks行业排名中位列前22% 当前Zacks评级为3级(持有) [3] - 过去30天内 两位分析师上调当季每股收益预期 无人下调 共识预期从49美分升至50美分 [3] 交易策略分析 - 分析师态度与高隐含波动率结合 可能预示交易机会形成 经验丰富的交易者常通过出售高隐含波动率期权溢价来捕捉时间价值衰减 [4] - 这类策略的核心目标是标的股票在到期时波动幅度低于市场预期 [4]

Key Takeaways XRAY is leveraging Azento and 3D imaging tech to grow in the $20B global tooth replacement market. Expanded R&D spend and Q1 margin gains highlight XRAY's focus on product innovation and efficiency. Soft CAD/CAM demand in Germany and forex headwinds are pressuring XRAY's 2025 sales expectations.DENTSPLY SIRONA (XRAY) is well-positioned for growth due to its new digital-implant workflowand continued focus on research and development. However, forex headwinds and demand softness in Europe rema ...

CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 (the “notes”). The Offering is expected to close on June 12, 2025, subject to customary closing conditions. The notes will bear interest at a fixed rate of 8.375% per year until September 12, 2030 (the “First Reset Date”). On and after t ...

投资观点 - 分析师建议投资者避免投资DENTSPLY SIRONA Inc (NASDAQ: XRAY) 股票已有7年半时间 [1] - 分析师采用量化投资策略 结合基本面分析和动量研究 通过自研软件追踪股价中隐含的乐观与悲观情绪 [1] - 投资策略聚焦于发掘市场预期与可能结果之间的差异 选择未来几个月可能带来意外表现的公司 [1] 持仓情况 - 分析师持有XRAY的多头头寸 包括股票、期权或其他衍生品 [2] - 计划立即购买200股XRAY股票 未来一年内若公司发展良好将增持更多 [2]

Investors might want to bet on Dentsply International (XRAY) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this dental products manufacturer, should get reflected in its stock price. After all, empirical research shows a str ...

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or The Cooper Companies (COO) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings esti ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the ...

CHARLOTTE, N.C., May 29, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Matthew E. Garth has been appointed Executive Vice President and Chief Financial Officer, effective May 30, 2025. Mr. Garth brings nearly 30 years of proven financial management expertise to Dentsply Sirona, with a focus on driving value creation. He most recently served as Chief Financial Officer & Chief Administrative Officer of The Scotts Miracle-Gro Company, a g ...